Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Hydration Pharmaceuticals CoASX:HPC 3-Year EPS without NRI Growth Rate is 51.10% as of Dec. 2025, which is 25% above its 10-year median of 40.75. The stock has 3 warning signs investors should review. Among 263 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks better than 92.02% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 51.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 5 years, the highest 3-Year average EPS without NRI Growth Rate of The Hydration Pharmaceuticals Co was 51.10% per year. The lowest was 30.40% per year. And the median was 40.75% per year.
The Hydration Pharmaceuticals Co (ASX:HPC) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
The Hydration Pharmaceuticals Co 3-Year EPS without NRI Growth Rate Related Terms
ASX:HPC vs SYY, USFD, PFGC: 3-Year EPS without NRI Growth Rate Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co 3-Year EPS without NRI Growth Rate vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate falls into.
The Hydration Pharmaceuticals Co 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 51.10% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a 3-Year EPS without NRI Growth Rate of 51.10% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Hydration Pharmaceuticals Co and its competitors. This is 25% above median its historical median of 40.75. Over the past decade, The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate has ranged from 30.40 to 51.10. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #21 out of 263 companies in the Retail - Defensive industry, placing it in the top 8%.
Is The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate too high?
The Hydration Pharmaceuticals Co's current 3-Year EPS without NRI Growth Rate of 51.10% is 25% above median its 10-year median of 40.75. Over the past 10 years, this metric has ranged from a low of 30.40 to a high of 51.10. The Retail - Defensive industry median 3-Year EPS without NRI Growth Rate is 7.80. The Hydration Pharmaceuticals Co's value of 51.10% is 555.1% above this industry median. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #21 out of 263 companies in the Retail - Defensive industry, which is in the top quartile — a strong position relative to peers.
How does The Hydration Pharmaceuticals Co's 3-Year EPS without NRI Growth Rate compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #21 out of 263 companies for 3-Year EPS without NRI Growth Rate. This places The Hydration Pharmaceuticals Co in the top 8% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 7.80. The Hydration Pharmaceuticals Co's value of 51.10% is 555.1% above this benchmark. Historically, The Hydration Pharmaceuticals Co's own 3-Year EPS without NRI Growth Rate has ranged from 30.40 to 51.10 over the past decade. While the company's 10-year median is 40.75 vs. the industry median of 7.80, The Hydration Pharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Retail - Defensive company?
The median 3-Year EPS without NRI Growth Rate among Retail - Defensive companies is 7.80, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Hydration Pharmaceuticals Co's current 3-Year EPS without NRI Growth Rate of 51.10% is 555.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median 3-Year EPS without NRI Growth Rate is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current 3-Year EPS without NRI Growth Rate is 51.10%, which is 25% above median its own 10-year median of 40.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current 3-Year EPS without NRI Growth Rate of 51.10%. The current 3-Year EPS without NRI Growth Rate is 51.10%, which is 25% above median its 10-year median of 40.75 and 555.1% above the Retail - Defensive industry median of 7.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current 3-Year EPS without NRI Growth Rate is 51.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 
